DESC NEWS

We are proud to share that Dr. Wilkes has been recognized by Newsweek as one of Ohio’s top retinal surgeons in its America’s Leading Doctors ranking. This prestigious recognition highlights his commitment to providing exceptional retinal care and outstanding patient outcomes.

Dayton Eye Surgery Center is honored to have Dr. Wilkes, a highly skilled retinal surgeon performing procedures at our facility, delivering advanced surgical care and helping patients achieve the best possible vision outcomes. Congratulations to Dr. Wilkes on this well-deserved recognition.

We are proud to share that Dr. Hasan has been recognized by Newsweek as one of Ohio’s top glaucoma surgeons in its America’s Leading Doctors ranking. This prestigious honor reflects his dedication to clinical excellence, advanced surgical expertise, and outstanding patient care.

Dayton Eye Surgery Center is honored to have Dr. Hasan providing exceptional glaucoma surgical care at our facility. His commitment to preserving and improving vision continues to make a meaningful difference in the lives of our patients. Congratulations to Dr. Hasan on this well-deserved recognition.

Dayton Eye Surgery Center is proud to be recognized in Newsweek’s America’s Best Ambulatory Surgery Centers rankings. This distinction reflects our commitment to providing exceptional surgical care, outstanding patient experiences, and a safe, high-quality environment for every patient we serve.

At Dayton Eye Surgery Center, our team is dedicated to delivering the highest standard of care from the moment patients walk through our doors until they return home. We continually strive for excellence in patient safety, clinical outcomes, and personalized service, ensuring that every patient receives the best care possible.

We are honored by this recognition and remain committed to serving our community with compassion, expertise, and excellence.

Newsweeks

Leading Doctors

Dr. Altman recently performed his first procedure utilizing the iDose® TR, an innovative glaucoma treatment developed by Glaukos. This FDA-approved implant is designed to provide continuous medication delivery directly inside the eye, helping to reduce intraocular pressure for patients with open-angle glaucoma or ocular hypertension.

The successful use of iDose TR reflects our ongoing commitment to offering the latest advancements in ophthalmic care. By incorporating cutting-edge technologies and treatment options, our surgeons continue to enhance patient outcomes while improving convenience and quality of life for those managing chronic eye conditions.

We congratulate Dr. Altman on this milestone and look forward to expanding access to innovative glaucoma therapies for our patients.